Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Annals of Nuclear Medicine|June 9, 2009
Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumorsHirofumi Hanaoka, Hideyuki Tominaga, Keiich Yamada, et al.
Anticancer Research|June 10, 2019
Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell CarcinomaHideyuki Takahashi, Koichi Sakakura, Yukiko Arisaka, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 11, 2024
Total lesion glycolysis by 18F-fluorodeoxyglucose positron emission tomography predicts tumor aggressiveness in patients with extrahepatic bile duct carcinomaRyosuke Fukushima, Norifumi Harimoto, Shunsuke Kawai, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 28, 2003
[Evaluation of efficiency of a semiconductor gamma camera]Hidenori Otake, Tetsuya Higuchi, Yasunao Takeuchi, et al.
Anticancer Research|December 7, 2016
Usefulness of 18F-α-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung CancerKyoichi Kaira, Tetsuya Higuchi, Noriaki Sunaga, et al.
Experimental Dermatology|December 5, 2008
Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunitySandra Balkow, Karin Loser, Mathias Krummen, et al.
Oncology Reports|June 11, 2009
Dual functional molecular imaging probe targeting CD20 with PET and optical imagingPramila Paudyal, Bishnuhari Paudyal, Yasuhiko Iida, et al.
Japanese Journal of Radiology|May 25, 2011
Pulmonary artery intimal sarcoma: the role of ¹⁸F-fluorodeoxyglucose positron emission tomography in monitoring response to treatmentEnrique Leonardo P Ote, Noboru Oriuchi, Go Miyashita, et al.
Pageof 15